Cargando…
SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
The world has been suffering from COVID-19 disease for more than a year, and it still has a high mortality rate. In addition to the need to minimize transmission of the virus through non-pharmacological measures such as the use of masks and social distance, many efforts are being made to develop a v...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364403/ https://www.ncbi.nlm.nih.gov/pubmed/34403674 http://dx.doi.org/10.1016/j.ijbiomac.2021.08.076 |
_version_ | 1783738526405230592 |
---|---|
author | Fathizadeh, Hadis Afshar, Saman Masoudi, Mahmood Reza Gholizadeh, Pourya Asgharzadeh, Mohammad Ganbarov, Khudaverdi Köse, Şükran Yousefi, Mehdi Kafil, Hossein Samadi |
author_facet | Fathizadeh, Hadis Afshar, Saman Masoudi, Mahmood Reza Gholizadeh, Pourya Asgharzadeh, Mohammad Ganbarov, Khudaverdi Köse, Şükran Yousefi, Mehdi Kafil, Hossein Samadi |
author_sort | Fathizadeh, Hadis |
collection | PubMed |
description | The world has been suffering from COVID-19 disease for more than a year, and it still has a high mortality rate. In addition to the need to minimize transmission of the virus through non-pharmacological measures such as the use of masks and social distance, many efforts are being made to develop a variety of vaccines to prevent the disease worldwide. So far, several vaccines have reached the final stages of safety and efficacy in various phases of clinical trials, and some, such as Moderna/NIAID and BioNTech/Pfizer, have reported very high safety and protection. The important point is that comparing different vaccines is not easy because there is no set standard for measuring neutralization. In this study, we have reviewed the common platforms of COVID-19 vaccines and tried to present the latest reports on the effectiveness of these vaccines. |
format | Online Article Text |
id | pubmed-8364403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83644032021-08-15 SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review Fathizadeh, Hadis Afshar, Saman Masoudi, Mahmood Reza Gholizadeh, Pourya Asgharzadeh, Mohammad Ganbarov, Khudaverdi Köse, Şükran Yousefi, Mehdi Kafil, Hossein Samadi Int J Biol Macromol Review The world has been suffering from COVID-19 disease for more than a year, and it still has a high mortality rate. In addition to the need to minimize transmission of the virus through non-pharmacological measures such as the use of masks and social distance, many efforts are being made to develop a variety of vaccines to prevent the disease worldwide. So far, several vaccines have reached the final stages of safety and efficacy in various phases of clinical trials, and some, such as Moderna/NIAID and BioNTech/Pfizer, have reported very high safety and protection. The important point is that comparing different vaccines is not easy because there is no set standard for measuring neutralization. In this study, we have reviewed the common platforms of COVID-19 vaccines and tried to present the latest reports on the effectiveness of these vaccines. Elsevier B.V. 2021-10-01 2021-08-14 /pmc/articles/PMC8364403/ /pubmed/34403674 http://dx.doi.org/10.1016/j.ijbiomac.2021.08.076 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Fathizadeh, Hadis Afshar, Saman Masoudi, Mahmood Reza Gholizadeh, Pourya Asgharzadeh, Mohammad Ganbarov, Khudaverdi Köse, Şükran Yousefi, Mehdi Kafil, Hossein Samadi SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review |
title | SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review |
title_full | SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review |
title_fullStr | SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review |
title_full_unstemmed | SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review |
title_short | SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review |
title_sort | sars-cov-2 (covid-19) vaccines structure, mechanisms and effectiveness: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364403/ https://www.ncbi.nlm.nih.gov/pubmed/34403674 http://dx.doi.org/10.1016/j.ijbiomac.2021.08.076 |
work_keys_str_mv | AT fathizadehhadis sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview AT afsharsaman sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview AT masoudimahmoodreza sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview AT gholizadehpourya sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview AT asgharzadehmohammad sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview AT ganbarovkhudaverdi sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview AT kosesukran sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview AT yousefimehdi sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview AT kafilhosseinsamadi sarscov2covid19vaccinesstructuremechanismsandeffectivenessareview |